Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The synaptic pathology of cognitive life
William G. Honer, Alfredo Ramos‐Miguel, Jehan Alamri, et al.
Dialogues in Clinical Neuroscience (2019) Vol. 21, Iss. 3, pp. 271-279
Open Access | Times Cited: 20

Showing 20 citing articles:

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Johanna Nilsson, Johan Gobom, Simon Sjödin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
Johanna Nilsson, Katheryn A Q Cousins, Johan Gobom, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 5, pp. 1775-1784
Open Access | Times Cited: 41
Late‐life physical activity relates to brain tissue synaptic integrity markers in older adults
Kaitlin B. Casaletto, Alfredo Ramos‐Miguel, Anna M. VandeBunte, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 11, pp. 2023-2035
Open Access | Times Cited: 40
MicroRNA-455-3P as a peripheral biomarker and Therapeutic Target for Mild Cognitive Impairment and Alzheimer’s disease
Md. Ariful Islam, Omme Fatema Sultana, M.D Dr.Sudhakar Bandari, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102459-102459
Closed Access | Times Cited: 10
Cyclophilin D (CypD) ablation prevents neurodegenerative and cognitive damage induced by caspase-3 cleaved tau.
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Gail V.W. Johnson, et al.
Free Radical Biology and Medicine (2025)
Closed Access | Times Cited: 1
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
John McDaid, Sarah Mustaly-Kalimi, Grace E. Stutzmann
Cells (2020) Vol. 9, Iss. 12, pp. 2655-2655
Open Access | Times Cited: 54
MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease
Subodh Kumar, Hallie Morton, Neha Sawant, et al.
Redox Biology (2021) Vol. 48, pp. 102182-102182
Open Access | Times Cited: 54
The interplay between age at menopause and synaptic integrity on Alzheimer’s disease risk in women
Madeline Wood Alexander, William G. Honer, Rowan Saloner, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access
Room for Two: The Synaptophysin/Synaptobrevin Complex
Dustin N. White, Michael H. B. Stowell
Frontiers in Synaptic Neuroscience (2021) Vol. 13
Open Access | Times Cited: 23
Dietary Melatonin Therapy Alleviates the Lamina Cribrosa Damages in Patients with Mild Cognitive Impairments: A Double-Blinded, Randomized Controlled Study
Lei Xu, Haixiang Yu, Hongbin Sun, et al.
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 23
Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample
Alfredo Ramos‐Miguel, Andrea A. Jones, Vladislav Petyuk, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 5, pp. 755-770
Closed Access | Times Cited: 16
Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study
Faraz Ahmad, Hannah Mein, Jing Yu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9727-9727
Open Access | Times Cited: 15
Transcranial Photobiomodulation Therapy Ameliorates Perioperative Neurocognitive Disorder Through Modulation of Mitochondrial Function in Aged Mice
Xiaojun Zhang, Wensi Wu, Yuelian Luo, et al.
Neuroscience (2021) Vol. 490, pp. 236-249
Open Access | Times Cited: 13
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Javiera Arcos, Felipe Grünenwald, Denisse Sepúlveda, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
A multilayer network analysis of Alzheimer's disease pathogenesis: Roles for p‐tau, synaptic peptides, and physical activity
Andrea A. Jones, Alfredo Ramos‐Miguel, Kristina M. Gicas, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 8012-8027
Open Access | Times Cited: 1
Brain γ-Tocopherol Levels Are Associated with Presynaptic Protein Levels in Elderly Human Midfrontal Cortex
Francisca A. de Leeuw, William G. Honer, Julie A. Schneider, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 2, pp. 619-627
Open Access | Times Cited: 8
Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer’s Disease
Bin Zhou, Masanori Fukushima
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8661-8661
Open Access | Times Cited: 7
Dysregulation of synaptic-related genes of neuroimmune networks within peripheral blood mononuclear cells in major depressive disorder
Anny Silva Adri, Adriel Leal Nóbile, D. Alburquerque, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Novel microRNA-455-3p mouse models to study Alzheimer’s disease pathogenesis
Subodh Kumar, H. Mortan, Neha Sawant, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
René L. Vidal, Javiera Arcos, Felipe Grünenwald, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top